T cells have the potential to live for a very long time – but their ageing may accelerate when a patient has leukaemia, according to a groundbreaking new study.
Researchers in the USA have unveiled new findings about the ageing process of T cells,...
1 year ago
An immunosuppressant drug can “supercharge” checkpoint inhibitor therapy for Hodgkin’s lymphoma, researchers have reported.
The new combination is backed by both a phase I clinical trial and by preclinical studies.
The research involved the JAK in...
1 year ago
